Wednesday 22 June 2016
“For an industry progressing towards personalised medicines, 3D printing is starting to sound attractive. However, it is a technology that truly adheres to the ‘rubbish in, rubbish out’ adage – and that means we really need to understand our powders.”
In a recent article with The Medicine Maker, Tim Freeman, Managing Director of Freeman Technology, looks at the future of 3D printing and the need for the industry to pay close attention to powder characterisation.
To read the article in full please click here.